An Open-Label, Single Arm Clinical Study to Evaluate the Safety of HGLG-032406 (IN-100001206) in Healthy Adult Females. - Nil

Himalaya Wellness Company0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1.Healthy adult females within age group of 18 to 40 years.
•2.Healthy females as determined by the investigator based on a medical evaluation including medical history, physical examinations, and laboratory examinations.
•3.Subjects willing to sign an informed consent document.
•4.Subjects willing to adhere to protocol requirements throughout the study period.
•5.Subjects who have not participated in any clinical study in the past 30 days

•1.Subjects with known clinically significant serious cardiovascular, neurological, respiratory, gastrointestinal, genitourinary, congenital or any other disorder as determined by the investigator.
•2.Women who are pregnant, nursing, or planning a pregnancy during study entry and throughout the duration of the study.
•3.Subjects with lactose intolerance (as the IP is to be taken with milk).
•4.Subjects with known allergies to any of the ingredients of the investigational product.
•5.Subjects with clinically significant pre-existing systemic disease necessitating long-term medications as determined by the investigator.
•6.Subjects not willing to refrain from using adequate contraception and hormonal medications one month prior and during the study.
•7.Subjects not willing to refrain from taking any other similar supplements during the study period.
•8.Subjects not willing to abstain from excessive intake of recreational products like tobacco/pan chewing, smoking, alcohol and any other as determined by the investigator during the study period.

发起方